Successfully Using NK Cells to Combat Ovarian Tumors

In Sophie's work, she found that expanding NK cells transforms them to a highly cytotoxic subtype, hence serving the potential for cancer immunotherapy. Her work involved in vivo and in vitro studies, both with astonishing results. Read through her paper published in Cancer Immunology Research.

Paper: Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model.

News: https://brighterworld.mcmaster.ca/articles/mcmaster-scientists-developing-a-new-immunotherapy-for-ovarian-cancer/